(PRESS RELEASE) CHARENTON-LE-PONT — EssilorLuxottica continues to support the Ophthalmology Futures Forums European Forum on 7 September 2023, the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) sub-specialty day 2023, and the ESCRS iNovation Day 2023, both on 8 September 2023 in Vienna, Austria. EssilorLuxottica will share the latest findings of the Essilor Stellest lens and its role in myopia management at the events.
From advancing research and innovation and sharing expertise at international forums and events, to developing key partnerships and more, EssilorLuxottica remains at the forefront to help further education and understanding on myopia and provide innovative myopia control solutions for children. As part of these efforts, EssilorLuxottica is supporting the Ophthalmology Futures Forums for the third year in a row as a silver sponsor. Olga Prenat, Head of Medical and Professional Affairs, EssilorLuxottica, will participate in a panel discussion titled, ‘Myopia in the Digital Age: Is Technology the Answer?’ chaired by Associate Prof. Marcus Ang from Singapore and Ian Flitcroft from Ireland at the European Forum on 7 September 2023 at 14.00-14.30 CET. EssilorLuxottica will also have a table-top booth where attendees can find out more about the Essilor Stellest lens. The agenda for the European Forum can be found here and interested attendees can register for the event here.
EssilorLuxottica will also host a satellite session at the WSPOS sub-specialty day 2023 featuring Prof. Dominique Bremond-Gignac, Head of Ophthalmology Department, University Hospital Necker-Enfants Malades, France, and Prof. Arnaud Sauer, Paediatric ophthalmologist, University Hospitals of Strasbourg, France. Olga Prenat will present the four-year clinical trial results of the Essilor Stellest lenses. This satellite session will take place on September 8, 2023, at 10.15-10.45 am CET and will be moderated by Dr. Ken K. Nischal, WSPOS Co-founder and Division Chief, Pediatric Ophthalmology, Strabismus, and Adult Motility, Professor of Ophthalmology at the University of Pittsburgh, School of Medicine. Interested attendees can register for the event here and visit EssilorLuxottica’s booth.
EssilorLuxottica is also a gold-level supporter of the WSPOS independent medical education program.
For the first time in 2023, EssilorLuxottica will also support the European Society of Cataract and Refractive Surgeons (ESCRS) iNovation Day 2023 as a silver sponsor. This new program, launched in 2022, will bring together international clinical and business experts, with the goal of addressing the most urgent clinical needs and barriers to success in anterior segment care. Olga Prenat will take part in a panel discussion on the topic: “Myopia: The next pandemic?” chaired by Ken K. Nischal and Jim Mazzo on September 8 from 14:20 to 15:00 CET. Registration is open here for attendees wishing to attend the panel.
Olga Prenat, head of medical and professional affairs, EssilorLuxottica, said, “By participating in these important professional events, EssilorLuxottica reaffirms its commitment to address the myopia pandemic. Such events provide a valuable forum to share the latest evidence-based insights as well as the latest solutions for myopia management with the medical community.”
Advertisement
The Company presented the four-year clinical trial results of its myopia control innovation Essilor Stellest lens for the first time at the 2023 ARVO annual meeting in New Orleans, Louisiana. The findings show that the Essilor Stellest lens continues to exhibit strong efficacy in slowing myopia progression and axial elongation in children in the fourth year of the trial.
